In today’s recent session, 0.66 million shares of the Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) have been traded, and its beta is 1.92. Most recently the company’s share price was $0.86, and it changed around $0.05 or 6.61% from the last close, which brings the market valuation of the company to $3.43M. QNRX at last check was trading at a discount to its 52-week high of $6.18, offering almost -618.6% off that amount. The share price’s 52-week low was $0.48, which indicates that the recent value has risen by an impressive 44.19% since then. We note from Quoin Pharmaceuticals Ltd ADR’s average daily trading volume that its 10-day average is 13.36 million shares, with the 3-month average coming to 2.53 million.
Quoin Pharmaceuticals Ltd ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended QNRX as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Quoin Pharmaceuticals Ltd ADR is expected to report earnings per share of -0.49 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Instantly QNRX has been showing a green trend so far today with a performance of 6.61% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.9129 on recent trading dayincreased the stock’s daily price by 5.79%. The company’s shares are currently down -82.44% year-to-date, but still down -0.37% over the last five days. On the other hand, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) is 67.59% up in the 30-day period. We can see from the shorts that 19172.0 shares have been sold at a short interest cover period of 0.2 day(s).
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Quoin Pharmaceuticals Ltd ADR share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 25.73 percent over the past six months and at a 79.05% annual growth rate that is well above the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 74.90% in revenue this quarter, and will report an increase of 76.00% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 67.35%.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR’s next quarterly earnings report is expected to be released on 2024-Nov-06.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.10% of Quoin Pharmaceuticals Ltd ADR shares, and 7.73% of them are in the hands of institutional investors. The stock currently has a share float of 7.98%.
